Posted On: 01/08/2015 11:38:13 AM
Post# of 223
BioPharmX Corporation To Present At OneMed Forum SF 2015 Conference
MENLO PARK, Calif., Jan. 8, 2015 /PRNewswire/ -- BioPharmX Corporation (OTCQB: BPMX), a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that Jim Pekarsky, chief executive officer and co-founder of BioPharmX, will present at the OneMed Forum SF 2015 Conference on Monday, January 12 at 3:00 p.m. PST at the Marriott Marquis in San Francisco.
Mr. Pekarsky will provide an overview of BioPharmX's business strategy as it pursues bringing novel products to market, including the company's recent commercial launch of VioletTM iodine, a new, once-daily pill for relief of premenstrual breast discomfort. Violet iodine is currently available at Walgreen Co.'s drugstore.com™ web store and BioPharmX anticipates rolling out Violet iodine to other large retail chains.
A live and archived webcast of the presentation will be available on the Investors page of the BioPharmX website at http://biopharmx.investorroom.com/.
MENLO PARK, Calif., Jan. 8, 2015 /PRNewswire/ -- BioPharmX Corporation (OTCQB: BPMX), a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that Jim Pekarsky, chief executive officer and co-founder of BioPharmX, will present at the OneMed Forum SF 2015 Conference on Monday, January 12 at 3:00 p.m. PST at the Marriott Marquis in San Francisco.
Mr. Pekarsky will provide an overview of BioPharmX's business strategy as it pursues bringing novel products to market, including the company's recent commercial launch of VioletTM iodine, a new, once-daily pill for relief of premenstrual breast discomfort. Violet iodine is currently available at Walgreen Co.'s drugstore.com™ web store and BioPharmX anticipates rolling out Violet iodine to other large retail chains.
A live and archived webcast of the presentation will be available on the Investors page of the BioPharmX website at http://biopharmx.investorroom.com/.
(0)
(0)
